Table III.
Univariate logistic regression models for IL-2
| Variables | IL-2 | P-value | |
|---|---|---|---|
| OR | 95% CI for OR | ||
| SARS-CoV-2 IgG (positive vs. negative) | 0.74 | 0.35; 1.55 | 0.422 |
| SARS-CoV-2 IgA + M (positive vs. negative) | 2.60 | 1.23; 5.67 | 0.014 |
| Sex (male vs. female) | 0.84 | 0.40; 1.75 | 0.644 |
| Age | 1.00 | 0.96; 1.03 | 0.797 |
| Type of disease (UC vs. CD) | 0.59 | 0.25; 1.38 | 0.225 |
| 5-ASA (yes vs. no) | 0.50 | 0.13; 1.63 | 0.269 |
| Thiopurines (yes vs. no) | 0.81 | 0.38; 1.71 | 0.590 |
| Infliximab (yes vs. no) | 0.62 | 0.30; 1.28 | 0.197 |
| Vedolizumab (yes vs. no) | 0.60 | 0.27; 1.33 | 0.210 |
| Prednisone (yes vs. no) | 0.47 | 0.16; 1.30 | 0.151 |
| Smokers (yes vs. no) | 5.55 | 1.72; 24.93 | 0.009 |
| CDAI (quantitative) | > 0.99 | > 0.99; 1.00 | 0.990 |
OR 95% CI – odds ratio with 95% confidence intervals.